Why the study?
Sudden cardiac death is often associated with hereditary genetic disease requiring sequencing of stored FFPE tissue to identify causal variants, but differences in sensitivity and precision between massive parallel sequencing assays needed comparison.
Does modified Twist sequencing improve sensitivity and precision compared to HaloPlex HS for detecting genetic variants in FFPE tissue from sudden cardiac death victims?
Does modified Twist sequencing improve sensitivity and precision compared to HaloPlex HS for detecting genetic variants in FFPE tissue from sudden cardiac death victims?
The Twist sequencing method outperforms HaloPlex HS in coverage uniformity and maintains high sensitivity for variant detection in severely fragmented FFPE samples from sudden cardiac death victims.
Answers are grounded in this paper and cite their sources.
May improve genetic testing in sudden cardiac death autopsies; leaves open prospective validation before clinical adoption.
Sudden cardiac death (SCD) is a tragic and traumatic event. SCD is often associated with hereditary genetic disease and in such cases, sequencing of stored formalin fixed paraffin embedded (FFPE) tissue is often crucial in trying to find a causal genetic variant. This study was designed to compare two massive parallel sequencing assays for differences in sensitivity and precision regarding variants related to SCD in FFPE material. From eight cases of SCD where DNA from blood had been sequenced using HaloPlex, corresponding FFPE samples were collected six years later. DNA from FFPE samples were amplified using HaloPlex HS, sequenced on MiSeq, representing the first method, as well as amplified using modified Twist and sequenced on NextSeq, representing the second method. Molecular barcodes were included to distinguish artefacts from true variants. In both approaches, read coverage, uniformity and variant detection were compared using genomic DNA isolated from blood and corresponding FFPE tissue, respectively. In terms of coverage uniformity, Twist performed better than HaloPlex HS for FFPE samples. Despite higher overall coverage, amplicon-based HaloPlex technologies, both for blood and FFPE tissue, suffered from design and/or performance issues resulting in genes lacking complete coverage. Although Twist had considerably lower overall mean coverage, high uniformity resulted in equal or higher fraction of genes covered at ≥ 20X. By comparing variants found in the matched samples in a pre-defined cardiodiagnostic gene panel, HaloPlex HS for FFPE material resulted in high sensitivity, 98.0% (range 96.6-100%), and high precision, 99.9% (range 99.5-100%) for moderately fragmented samples, but suffered from reduced sensitivity (range 74.2-91.1%) in more severely fragmented samples due to lack of coverage. Twist had high sensitivity, 97.8% (range 96.8-98.7%) and high precision, 99.9% (range 99.3-100%) in all analyzed samples, including the severely fragmented samples.
No takes yet. Share an insight, caveat, or question.
Adolfsson et al. (2021) studied Sudden cardiac death (n=8). Modified Twist sequenced on NextSeq vs. HaloPlex HS sequenced on MiSeq was evaluated on Sensitivity and precision regarding variants related to sudden cardiac death in FFPE material.
Synapse has enriched 10 related papers. Consider them for comparative context: